A hallmark in the pathogenesis of cancer is the increased expression of heat shock proteins (Hsps) and other molecular chaperones observed in many tumor types, which is considered to be an adaptive response to enhance tumor cell survival. Heat shock transcription factor 1 (Hsf1) is a major transactivator of Hsp induction and has been proposed to affect tumor initiation and progression, regulating expression of Hsps and other molecular targets. In this report, we provide direct in vivo evidence that Hsf1 plays a critical role in the evolution of spontaneous tumors arising in p53 À/À mice. Thus, loss of Hsf1 function did not prolong tumor-free survival, but surprisingly altered the spectrum of tumors that arose in p53 À/À mice. Tumor development is rapid in p53 À/À mice, which predominantly (about 70%) succumb to lymphomas. In contrast, hsf1
Introduction
Tumorigenesis is an evolutionary multistep process that involves selection of genetic and epigenetic alterations allowing evasion of mechanisms that limit cell proliferation or cell death (Hanahan and Weinberg, 2000) . However, this traditional tumorigenesis paradigm has been revised by observations that prominent stromal components in the tumor microenvironment, including stromal fibroblasts, infiltrating immune cells, blood and lymphatic vascular networks, extracellular matrix and soluble factors such as cytokines and growth factors, play critical roles in tumor initiation and progression (Hill et al., 2005; Li and Dalton, 2006) . Furthermore, recent work has suggested a more complex network of interaction between cancer, mostly of epithelial origin and the tumor microenvironment in which tumorigenic epithelium can exert strong selective pressure yielding a highly proliferative stromal mesenchyme that has undergone genetic alterations such as loss of p53 (Hill et al., 2005) . Thus, cancer, as an outcome, reflects an interruption of normal communication (cross-talk) between stroma and mutated epithelium that is regulated by multiple molecular pathways. Therefore, understanding the complex signaling networks within and between the cancer cells and tumor tissues are a valid approach for identifying new targets of drug development for cancer treatment.
A cardinal function of molecular chaperones, including the heat shock proteins (Hsps), is to ensure proper folding of proteins, which is crucial for generating and regulating biological activity in the cell (Jolly and Morimoto, 2000; Bukau et al., 2006) . Defective protein folding or failure of the quality control mechanisms compromising essential cellular functions can result in disease, and based on the extensive literature on this topic, the critical involvement of Hsps in a wide range of human diseases, including cancer, has received especial attention (Jolly and Morimoto, 2000; Whitesell and Lindquist, 2005) . Thus, considering the essential guardian function of molecular chaperones in normal cell physiology, it is reasonable to hypothesize that their increased or constitutive expression observed in many tumor types, especially of epithelial origin, reflect a critical mechanism for maintaining tumor cell homeostasis (Ciocca and Calderwood, 2005) . In particular, evidence indicates that in addition to promoting tumor cell survival, inhibiting apoptotic cell death, and in general allowing cells to tolerate genetic and epigenetic alterations, molecular chaperones may exhibit critical function on the integrity of the tumor microenvironment; and thus tumor progression and perhaps metastasis. This study, therefore was undertaken to determine whether loss of heat shock transcription factor (Hsf1) function, a major transactivator of Hsp induction and other molecular targets (Xiao et al., 1999; Zhang et al., 2002) , plays a significant role in development and progression of cancer in conjunction with genetic alteration of the p53 tumor suppressor gene. In further support of this proposal, there is considerable evidence to support a role for Hsf1 and its target genes in cell survival by inhibiting cell death as well as cellular differentiation and promotion of inflammatory response, properties associated with tumor progression (Inouye et al., 2004) . In particular, studies with mice deficient in hsf1 generated by gene targeting strategy confirmed Hsf1 as the master regulator of Hsp expression in response to environmental stress (heat shock), but also established its critical involvement in development and differentiation-related processes at the whole organism level. For example, disruption of hsf1 causes prenatal lethality to different extent depending on the genetic background of the mouse due to placental defects. Furthermore, hsf1 À/À female mice exhibit complete infertility whereas male mice are fertile. In addition, hsf1 deficiency causes central nervous system defects (unpublished), neuronal defects (Takaki et al., 2006) and lack of spermatogenesis in conjunction with hsf2 deficiency (Wang et al., 2004) . These defects are linked to Hsf1-mediated pathways regulating expression of diverse array of target genes including Hsps, growth factors and cytokines in the mutant mice. The results support the concept that Hsf1 acts as capacitor for tumor evolution in that its functional inactivation suppresses lymphoma development, a prominent tumor type frequently arising spontaneously in the p53 À/À mouse model (Harvey et al., 1993; Liu et al., 2004) .
Results

Hsf1 deficiency alters the spectrum of tumors arising in p53
À/À mouse model The diverse functions of molecular chaperone in oncogenesis are as yet far from understood. Therefore, we asked whether Hsf1 plays a critical role in the evolution of spontaneous tumors arising in p53 À/À mice. To address this issue we crossed hsf1 À/À with p53 À/À mice and monitored cohorts of p53
À/À mice succumb to tumors arising early at around 10 weeks of age. By 35 weeks of age, all p53 À/À or hsf1
There was a slight delay in tumor incidence in hsf1
À/À mice, as 10.5% of the mice (n ¼ 4) were tumor-free for a longer period and succumbed to tumors at 60 weeks of age ( Figure 1a) . Surprisingly, whereas tumors arising in p53 À/À or hsf1 þ /À p53 À/À mice were predominantly lymphomas (around 70% of tumors; mostly T-cell lymphomas positive for CD4 and CD8; Jacks et al., 1994) , ablation of hsf1 in p53-mutant mice suppressed spontaneous lymphoma development. Thus,
À/À mice rarely developed lymphomas (around 8%), but exhibited increased incidence of other tumor types, including testicular carcinomas (30.3 versus 5.6% in p53 À/À male mice) and soft tissue sarcomas (50 versus 16.7% in p53 À/À mice) (Figure 1b) . A similar observation (suppression of lymphoma development) was made when analysing the spectrum of tumors arising in hsf1
þ /À mice compared to p53 þ /À mice ( Figure  1c and d) . Note that p53 þ /À mice develop lymphomas with a lower incidence than p53 À/À mice (six of 13 mice), and they arise at a later age. However, in our study, in a cohort of 12 hsf1 À/À p53 þ /À mice, lymphomas were absent and mice succumbed to other tumor types, arising with slightly accelerated kinetics as in p53 þ /À mice (median age was 83 weeks for p53 þ /À versus 69 weeks for hsf1
þ /À mice). However, the overall survival kinetics for the two groups were not statistically significant (P ¼ 0.82). No tumors were detected in cohorts of wild-type (hsf1
À/À (n ¼ 200) mice monitored over a period of 2 years (data not shown).
Histological characteristics of a representative testicular tumor and sarcoma arising in hsf1
À/À mice are presented in Figure 1 (panels e and f). Analysis of a limited number of testicular tumors (n ¼ 4) that arose in hsf1
À/À mice indicated that they were of germ-cell origin (Jiang and Nadeau, 2001 ). Thus, they were negative for placental alkaline phosphatase (PLAP) (marker for seminomas), but positive for germ cell nuclear antigen (GCNA) (marker for germ cell lineage) and proliferating cell nuclear antigen (PCNA) (marker for proliferating tumor cells) (Oosterhuis and Looijenga, 2005) . In summary, the data clearly demonstrated that loss of Hsf1 function altered the spectrum of tumors that arose in p53 À/À mice, indicating a tumor-modifying function for Hsf1 in the absence of the p53.
Normal repertoire of T-and B-cell populations in mice deficient in both hsf1 and p53 genes To investigate mechanisms underlying the suppression of spontaneous malignant lymphomas in p53 À/À mice with hsf1 loss, we determined whether the development of thymocytes or lymphocytes in peripheral lymphoid organs of hsf1
À/À mice is impaired. We found that the total number of thymocytes or splenocytes did not differ significantly among the different genotypes (wild type, hsf1 Figure S1 ). In addition, similar percentages of lymphocyte populations in thymus and peripheral lymphatic organs (spleen and lymph nodes (LNs)) were detected in wild-type, hsf1 Figure S2) . As a more vigorous test to determine whether the development of hsf1 À/À thymocytes and mature peripheral lymphocytes is suboptimal, we determined the capacity of bone marrow (BM) cells from wild-type or hsf1 À/À mice to reconstitute the hematopoietic system of lethally irradiated wild-type or hsf1 À/À mice. Analyses of hematopoietic cell development in the chimeric mice revealed that hsf1
À/À and wild-type BM cells are able to reconstitute to a similar extent (Supplementary Figure S3) . Collectively, these results suggest that hsf1 loss alone or in the context of p53 deficiency does not affect the repertoire of B and T lymphocytes in thymus or peripheral lymphoid organs, making it unlikely that a primary defect in T-cell 
mice showed extended tumor-free survival but no statistical significance (P ¼ 0.057). (b and d) Percentage of tumor incidence and spectrum between p53 À/À and hsf1
In b, the incidence for lymphomas is as follows: p53 À/À (26/36), and hsf1 À/À p53 À/À (3/38); for sarcomas, p53 À/À (6/36), and hsf1 À/À p53 À/À (19/38); for testicular tumors, p53 À/À (1/18 males) and hsf1 À/À p53 À/À (10/33 males); and for other tumors, p53 À/À (3/36) and hsf1 À/À p53 À/À (6/38). In d, the incidence for testicular tumors in hsf1 À/À p53 þ /À was 2/6 males. Percentage of testicular tumor incidence in male mice is indicated in parenthesis. (e) Histology and immunohistochemistry of testicular tumors from hsf1 À/À p53 À/À mice. Staining of paraffin-embedded sections with H&E or for GCNA, PCNA, or PLAP using specific antibodies. Magnification, Â 10. (f) Histology (H&E) of two representative sarcomas developed in hsf1
Role of Hsf1 in p53-mediated tumorigenesis J-N Min et al development accounts for the suppression of lymphomas in hsf1
Effects of Hsf1 on the tumor microenvironment in spontaneous tumors arising in p53-deficient mice To understand the basis for the suppression of lymphoma, and in particular to distinguish between direct effects of hsf1 deficiency in lymphocyte development or indirect effects on stromal microenvironment function, we generated chimeric mice. CD45.
þ lethally irradiated wild-type mice to produce chimeras in which hematopoietic cells, including lymphocyte lineage, were deficient in p53 À/À alone or in combination with hsf1. p53 À/À and hsf1 À/À p53 À/À BM were able to reconstitute to a similar extent (Figure 2a À/À chimeras also developed thymic lymphomas (mixed spectrum), but with significant delayed kinetic compared to p53 À/À chimeras (tumor incidence between 20 and 31 weeks after reconstitution). This result indicates that, for full suppression of lymphomas, both compartments (lymphocytes and tumor microenvironment) probably need to cooperate. Taken together, these results lead to the proposal that Hsf1 function to regulate parameters of lymphocyte development and components of the stromal microenvironment Hsf1 function has contributed to lymphoma suppression in hsf1
Hsf1
À/À p53 À/À T cells exhibit equivalent response to stimulation through T-cell receptor, but a lower sensitivity to interlukin2 compared to p53 À/À T cells One mechanism by which Hsf1 loss may impact lymphoma development in p53 À/À mice is through its suspected function to regulate cell proliferation and cytokine production (Wang et al., 2004) . The proliferative capacity of LNs following anti-CD3e or combined anti-CD3e and anti-CD28 stimulation in vitro was comparable between hsf1
À/À and p53 À/À mice (Figure 3a and b) . This suggests an intact signaling pathway through the T-cell receptor (TCR). However, in marked contrast to their normal proliferation through TCR stimulation, proliferation of hsf1
À/À cells to interleukin (IL2) stimulation was significantly reduced compared to p53 À/À cells (Figure 3c ). This was not owing to a difference in IL2 receptor (IL2R)-a (CD25) expression because comparable receptor levels were measured by fluorescence-activated cell sorting (FACS) in cell populations of both genotypes (data not shown). This result indicates that perhaps a defect in an intracellular signaling pathway downstream of IL2R in
À/À T cells may prevent cell activation and proliferation to cytokine stimulation. This defect may be extended to IL4-, IL7-, IL9-or IL15-mediated cell proliferation, cytokines that utilize receptors sharing a common gc subunit and that play a critical role in T-cell development (Leonard and Spolski, 2005) . For example, IL9 has been shown to promote lymphoma growth by inhibiting cell apoptosis (Renauld et al., 1995) .
Considering the combined evidence of a causal relationship between inflammatory response and cancer (Karin et al., 2006) , as well as role of the cytokine network in regulating many aspects of lymphocyte development, we suspected that diminished cytokine production by lymphocytes and perhaps by stromal cells in hsf1 À/À mice may be a contributing factor affecting spontaneous tumor development in p53 À/À mice. Thus, we determined the profile of cytokines using microarray analysis of mRNA expression within the T cells derived from hsf1
À/À or p53 À/À mice following mitogenic stimulation. Interestingly, we found that expression of several cytokines, including IL2, IL11, IL13, IL16, IL17 and tumor necrosis factor (TNF)-a, to be significantly lower in hsf1 (Figure 3d ), supporting our proposal. Furthermore, the basal level of IL2 expression (no stimulation) measured by reverse transcriptase-polymerase chain reaction was found to be significantly lower in thymocytes or PLNs from hsf1
Increased susceptibility of hsf1 À/À p53 À/À thymocytes to p53-independent apoptotic agents The p53 expression is induced in response to genotoxic injury and p53 À/À cells exhibit a marked resistance to apoptosis induced by g-or UV-irradiation, or etoposide (Clarke et al., 1993) . In contrast, p53 À/À cells remain sensitive to agents such as dexamethasone (Lowe et al., 1993) . To determine whether hsf1 loss may affect cell survival, we exposed thymocytes to various agents and apoptotic cell death was determined using Annexin-Vstaining followed by FACS analyses (Figure 4a ). Interestingly, p53 À/À thymocytes showed a marked resistance to apoptosis induced by heat shock or staurosporin, but not to dexamethasone compared to hsf1 À/À or wild-type cells. This increased resistance was not also seen in hsf1
À/À cells. However, consistent with previous observations, p53 À/À and hsf1 À/À p53 À/À thymocytes were equally resistant to genotoxic agents such as g-irradiation, etoposide and adriamycin that induce cell death through p53-dependent apoptotic pathways.
Hsf1 transcriptional activity is potentiated in response to various environmental stress stimuli, and indirect evidence suggests its increased expression and activation in tumor cells may lead to the increased expression of Hsps or other target genes in many tumors (Morimoto, 1998) . In fact, we have noted that ablation of p53 markedly increases Hsf1 expression level in thymocytes and, more interestingly, in lymphomas arising in p53 À/À mice. To investigate further the effects of this increase in Hsf1 expression, we determined expression of several (Figure 4b and c) . Interestingly, expression of Grp75 and Grp78 was also increased in p53 À/À lymphomas, however, this expression was not downregulated in hsf1 À/À p53 À/À lymphomas. We were unable to detect consistent expression of Hsp70 and Hsp25 in normal thymocytes or lymphomas derived from p53
À/À mice (data not shown). These results indicate that increased sensitivity to p53-independent apoptosis in association with a decrease in Hsp expression levels in hsf1 À/À p53 À/À mice may be contributing factors affecting spontaneous lymphoma development in p53 À/À mice.
Genomic instability and recurrent chromosomal changes in hsf1 À/À and wild-type MEFs, which lost their division potential after 5-7 passages in vitro ( Figure 5 ). p53 À/À cells or tumors are aneuploid (Fukasawa et al., 1997) , and we postulate that hsf1 loss in p53 À/À cells may impact genomic stability. We therefore used spectral karyotyping and G-banding to characterize the chromosomal complements of p53 À/À and hsf1
À/À MEFs. The analyses showed that each of these cell lines consisted of two clearly distinguishable cellular fractions: a near-diploid (2n ¼ 38 to 2n ¼ 42) fraction, which even contained some cells with apparently normal karyotypes, and a polyploidy fraction, whose chromosome number ranged from 64 (hypertriploid) to over 140 (hyperseptaploid). Interestingly, incidence of normal diploid metaphases was significantly higher in p53 À/À than in hsf1 (Figure 6a and b). However, the majority of metaphases in both cell lines exhibited marked aneuploid DNA content, whereas some of them, in addition, had structural þ and CD8 þ T cells using antibody-conjugated magnetic beads, recovered from the LNs of p53 À/À or hsf1 À/À p53 À/À mice, were activated with PMA (0.5 mM) and ionomycin (0.5 mg/ml) for 2 h at 371C. Total RNA was isolated and cDNA was prepared and 32 P-labeled cDNA were hybridized to membranes containing the indicated cytokine probes. The filters were exposed to PhosphorImager, and the intensity of hybridization was quantitated using internal controls (GAPDH, actin and HPRT). Statistic significance is indicated by asterisks; *Po0.05, **Po0.01, and ***Po0.001.
Role of Hsf1 in p53-mediated tumorigenesis J-N Min et al chromosome rearrangements. On the numerical side, we were not able to establish that any particular chromosome was gained or lost in a pattern different from purely random. On the side of structural rearrangements, we identified -in three out of 17 complete SKY karyotypes of the hsf1
À/À cell line -a recurrent deletion of chromosome 17, del(17) (B-ter) (Figure 6c  and d) . We compared the frequencies of numerical and structural changes between two cell lines and between their respective near-diploid and polyploid fractions, and found that the observed differences were not statistically significant except for the incidence of structural rearrangements that appeared to be higher (Pp0.03) in the polyploid fraction of hsf1
MEFs compared to polyploid p53 À/À cells. The above results suggest that hsf1 loss in p53 À/À cells provide for somewhat higher overall genomic instability, perhaps explaining the prevalence of solid tumors observed in hsf1
Discussion
Considering the central function of molecular chaperones in protein quality control and cellular homeostasis, the emerging concept predicts that successful breaching of anti-cancer defense mechanisms by pre-transformed cells reflects an increased demand on the molecular chaperone machinery (Jolly and Morimoto, 2000; Whitesell and Lindquist, 2005) . In this report, we provide direct evidence that elimination of Hsf1 has an impact on tumor evolution. In particular, our data suggest that loss of Hsf1 function is associated with an increase in p53-independent apoptosis and suppression of inflammatory cytokine secretion by lymphocytes and probably stromal cells. These, in conjunction with an increase in cellular genomic instability, which is generally considered an indicator for increased tumor incidence, are critical mechanisms to explain the changes in tumor spectrum observed. Our model, based on the data presented here, makes three predictions. The first prediction is that ablation of Hsf1 has inhibiting effects on hematopoietic tumor development based on its proposed function to regulate levels of molecular chaperones and other target molecules with prominent cytoprotective capacities. It is well known that, in addition to p53 and acute renal failure (ARF) activation, oncogene-driven abnormal division of precancerous cells also elicit a DNA-damage response, and both cooperate to arrest cell proliferation and cause cell death (Bartkova et al., 2005) . It is therefore reasonable to propose that although the guardian function of p53 molecules is lost in our mouse model, complementary mechanisms are activated including p53-independent apoptosis to inhibit progression of normal cell transformation. In this respect, the increased level of Hsf1 in p53 À/À pretransformed thymocytes and lymphomas and its target gene products (e.g. Hsp105, Hsp90a, Hsp60 and co-chaperone molecules Hop and Hip) observed in this study apparently represent a compensatory prosurvival mechanism to accelerate tumor evolution and advance cellular transformation. In addition, the selective suppression of lymphomas in our study could be explained by the proposal that elimination of hsf1 will generate conditions where the intensity of pro-survival mechanisms that enable tumor cells to cope with genetic alterations associated with neoplastic transformations are more selectively compromised in hematopoietic precancerous cells, which are more easily prone to apoptotic cell death by different inducers than other cell types or tissues.
The second prediction is that ablation of Hsf1 has inhibiting effects on tumor development by selectively depriving factors related to survival and growth in hematological malignancies. Hsf1 deficiency has been À/À , p53 À/À , and hsf1 À/À p53 À/À mice were exposed to different doses of dexamethasone, staurosporine, or heat shock. After 24 h incubation at 371C, apoptosis was determined using Annexin-V-staining and FACS analysis. PI was used to distinguish necrotic (PI-positive) versus PI-negative (live or early apoptotic) cells. Percent survival represents the PI-negative and Annexin V-negative cell population. Statistical significance is indicated by asterisks; *Po0.05. **Po0.01. Lower panels; thymocytes from wild-type, hsf1 À/À , p53 À/À or hsf1 À/À p53 À/À mice were exposed to different doses of g-irradiation, etoposide, or adriamycin. After 24 h incubation at 371C, apoptosis was determined as above. (b and c) Thymocytes from wild-type, hsf1 À/À , p53 À/À , hsf1 À/À p53 À/À , or thymic lymphomas arising in p53 À/À , or hsf1 À/À p53 À/À mice were analysed by immunoblotting using antibody specific to Hsf1, Hsps, and co-chaperones Hip and Hop and GRPs. b-Actin was used as a loading control. In b, lanes 1-4 represent normal thymocytes from wild-type, hsf1 À/À , p53 À/À or hsf1 À/À p53 À/À mice; lanes 5 and 6 represent lymphomas from p53 À/À mice; lanes 7-9 represent lymphomas from hsf1 À/À p53 À/À mice. Quantitative analysis of the immunoblots is presented in c. Statistical significance is indicated by asterisks; *Po0.01, **Po0.001 (one-way analysis of variance). shown to have negative effects on inflammatory cytokine production (Inouye et al., 2004) . Consistent with this, we have observed that hsf1 À/À mice and wild-type control mice elicit T-cell-mediated immune response to viral infections (e.g., lymphocytic choriomeningitis virus) of similar magnitude. However, the delayed type hypersensitivity reaction that is mediated by cytokines secreted by T cells migrated to the site of infection (footpad) was significantly reduced in hsf1 À/À mice (unpublished observation). This suggests that hsf1 À/À mice are able to induce a normal immune response, but the capacity of activated T cells to sustain cytokine production at the sites of virus replication in different tissues is compromised. In support of this, we present evidence in this study that the proliferative capacity of hsf1 À/À p53 À/À lymphocytes to TCR stimulation was intact, but their responsiveness to IL2 was impaired. In addition, the capacity of hsf1
lymphocytes to produce cytokines in response to mitogenic stimulation (phorbol 12-myristate 13-acetate (PMA)/ ionomycin) was impaired. Together, these data are consistent with a scenario that predicts that, during tumorigenesis, survival of pretransformed cells in hsf1
mice is compromised as a direct consequence of the impaired capacity of pre-tumorigenic lymphocytes and perhaps stroma cells to produce cytokines. A further defect in IL2 signaling in hsf1
À/À mice would further amplify this defect. Furthermore, upregulation of Hsp60 expression in p53 À/À lymphomas, known to induce, at least in macrophages, secretion of cytokines such as TNFa, IL6, IL12 and nitric oxide (Flohe et al., 2003) , may play a role in tumor progression providing precancerous cells with growth promoting stimuli. A greater dependence of hematological tumors (lymphomas), compared to other tumor types, on survival factors can also explain the selective suppression of lymphomas observed in our study. Finally, it is worthwhile to note that the role of Hsf1 in inflammation is not clear in the literature. This is because there are reports suggesting that hsf1 deficiency amplifies a lipopolysaccharide-induced inflammatory response by promoting nuclear factor-kappaB (NF-kB) and the expression of TNFa (Xiao et al., 1999; Knowlton, 2006) . Clearly, the possibility that Hsf1 function in inflammation may vary depending on the inducing stress stimuli will require further evaluation in additional animal models.
The third prediction is that hsf1 deficiency further increases genomic instability and may have differential effects on lymphoma versus solid tumor development in mice with p53 deficiency. There is a close link between genomic instability and cancer evolution. The general view is that increased genomic instability associated with loss of gatekeeper function of tumor-suppressor genes, including p53, ARF and Rb, and suppression of the DNA-damage response triggered as a result of aberrations in DNA replication leads to an increased number of cells with precancerous features (Donehower, 1997) . Along this line, during cancer progression associated with an increased diversity of cell populations with an aberrant genome that apparently reflects an effort of cells to secure survival, upregulation of molecular chaperones seems to be critical in providing conditions where genomic alterations can be easier tolerated. Consequently, compromising Hsf1 function in p53 À/À cells with an already unstable genome results in further increase in genomic instability. This is supported by data presented in this report showing that the incidence of structural rearrangements appeared to be higher in the polyploid fraction of hsf1 À/À p53 À/À MEFs than in polyploid p53
À/À cells. In this situation, we envisage following possible scenarios. In the first case, hsf1 ablation in p53 À/À cells will generate conditions of increasing genomic instability and elevated frequency of pre-malignant cell formation. This would promote the tumorigenesis process. An alternative scenario is also possible. In p53 À/À cells, elimination of hsf1 may reduce the barrier where genomic alteration can be tolerated and this can predispose cells to apoptotic cell death. There is the possibility that these scenarios vary between different tumor types, such as increased genomic instability in hsf1 À/À p53 À/À mice would predispose lymphoid cells to apoptosis while promoting solid tumor formation. Finally, the possibility that selective promotion of solid tumors by hsf1 ablation is a potential contributing factor to the altered tumor spectrum, a notion supported by the slightly accelerated kinetics of solid tumor incidence in hsf1 À/À p53 þ /À compared to p53 þ /À mice, cannot entirely be discounted. However, conclusive evaluation of this aspect requires further analyses including comparative chromosomal analyses of solid tumors arising in the above mouse strains and perhaps other mouse models for solid tumor formation, and such studies are underway.
In conclusion, tumor development may require a minimum level of homeostatic balance provided by Hsf1 and its target genes, allowing better control of genetic instability associated with loss of tumor suppressor p53 gene, and, in addition, improving requirements for the growth and survival of precancerous cells. Our study indirectly suggests a multiple-step tumorigenesis model in which three Hsf1-dependent, pro-survival mechanisms (inhibition of apoptotic cell death, supply of growth factors, and control of genetic stability) converge at a point to regulate spontaneous tumor development in a p53 À/À model. A direct consequence of the loss of these hsf1-mediated regulatory functions is a change in the spectrum of tumors arising in p53 À/À mice, providing a unique example directly linking a stress response involving Hsf1 and Hsp molecular chaperones to tumorigenesis.
Materials and methods
Animals
Generation of hsf1
À/À mice (C57BL/6 X 129Sv/EvJ) has been described previously (Zhang et al., 2002) . The p53 À/À mice (C57BL/6) were purchased from Jackson laboratory (Bar Harbor, ME, USA) and were crossed once with 129Sv/EvJ mice. Hsf1 and p53 heterozygous mice were intercrossed at the F1 generation to generate mice with different genotypes
